Integrating Discovery, Improving Efficiency

RubrYc Therapeutics Discovery-Stage Pipeline

RubrYc’s pipeline of products includes several proprietary therapeutic antibody programs targeting unique epitopes for oncology and immunology indications.

RTX-002
Anti-PD-1 Agonist
Autoimmune
RTX-003
Anti-CD 25 mediated Treg Depletion
Immuno-Oncology
RTX-005
Undisclosed Anti-GPCR
Oncology
RTX-006
Undisclosed Anti-GPCR
Oncology / Autoimmune Diseases